Lamictal Usage Carries Risk of Serious Skin Condition Stevens-Johnson Syndrome (SJS)
What’s the problem?
Lamotrigine – marketed under the brand name of Lamictal – is a prescription medication initially approved as an antiepileptic to prevent seizures. Later, the drug was approved for use against Bipolar I disorder. Unfortunately, Lamictal may cause Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), both life threatening skin disorders.
Lamictal & Stevens-Johnson Syndrome (SJS)
Stevens-Johnson Syndrome is a severe skin reaction that is known to occur as a side effect of several medications. It is highly debilitating and causes the skin to burn from the inside out, producing blisters, severe rashes, and skin separating from the body. When the skin lesions affect more than 30% of the body, the condition is referred to as Toxic Epidermal Necrolysis (TEN). Treatment in a hospital Intensive Care Unit (ICU) or Burn Unit is often required, and the conditions can be fatal in many cases.
Lamictal has also been linked to other dangerous conditions. The Food and Drug Administration (FDA) announced that the drug’s safety label would be updated to include a warning for aseptic meningitis, an inflammation of the protective membranes that cover the brain and spinal cord. The drug was also named among other anticonvulsant medications that studies showed put users taking them for the first time at an increased risk of suicide, attempted suicide, and violent deaths.
Do I have a Lamictal Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lamictal lawsuits. We are handling individual litigation nationwide and currently accepting new SJS and TEN cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one developed Stevens-Johnson syndrome or toxic epidermal nercolysis after taking Lamictal, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.